Free Essay

Memo Fda

In: Business and Management

Submitted By sabaejaz
Words 523
Pages 3
Sir as you are aware the recent deaths caused by the negligence of Robins and Robins has caused a stir in the area. The families are after the company and want to sue them to get compensated for the loss of loved ones they had to bear. In this chain of event FDA is also being dragged since FDA did not pass the Original Tracking Bar rule. A lot of people are saying that FDA is responsible for these, although it is clear that FDA does not have any liability towards the these victims.
Robins and Robins has caused this problem and they were one of the most active members who opposed this regulation and even bribed companies to be against it. they went ahead and they convinced the addicts to support them. Robins and Robins lobbied against this rule and got the rule stopped during the public comments period. Even after Robins and Robins was aware of the problem caused by their medicine they did not make a justified effort to recall their product. It could never be a 100% recall since there is no tracking methodology that can be used.
As far as the role played by FDA is concerned they did the right thing in stopping this bar code rule. They could not pass it without public’s consent and majority of them had voted against it. They thought it would violate their privacy rights. And also doing this would have increased the price of the medicine which was a big concern. As it is hard for people to afford medication as is and with this the price increase would have been tremendous. It was not only Robins and robins that lobbied against it but there were certain public interest groups involved as well.
The death and illness have been caused because of the negligence of Robins and Robins and not the FDA. In response to the concerns of public interest groups the FDA has stopped the rule.

The defense that FDA has is that the rule was created by FDA itself. However, the imposition of the rule was set aside because of protests from public interest groups. Further, Section 402 (a) applies to food and not to medicine. Even if it does apply to medicine it clearly indicates that anyone who sells any product in a defective condition is subject to liability.
Since, Robins and Robins was the strongest opponent to the rule requiring tracking code, the negligence claim should be against Robins and Robins and not against the FDA. It is clear that had Robins and Robins not lobbied the lives of the children could have been saved.

In this case another defense that FDA has is the General Negligence that Plaintiff(consumers) had showed in this situation. They had been against this law for bar codes with out being aware of the implications. It was a negligence on their part and not FDA
References:
www.fda.gov/ www.fda.gov/Food/default.htm http://biotech.law.lsu.edu/cases/products/402a-b.htm www.accessdata.fda.gov/scripts/cder/drugsatfda/ www.fda.com/ - www.fdanews.com/

Similar Documents

Premium Essay

Smart Mart Round 3

...Internal Company Memo: Organics 2.0 Over the last 6 years sales of organic food products grew from 23 billion to 52 billion worldwide, and are forecasted to grow at 20% a year. SmartMart has been a dominant player in the organics market since the 1970s, and has benefited from the mainstream acceptance of the organic label. The label and standards adopted by the USDA and the FDA at the turn of the century, currently prevents foods containing additives, artificial and chemical processing, and genetic modification from using the label organic. The use of the label has allowed many suppliers and farmers to adopt organic practices (to varying degrees) and thus organics are now also available from many of SmartMart's low-cost competitors. For example, customers who used to buy meticulously cultivated blueberries from SmartMart can now purchase four times as many "organic" blueberries from Big-Box Mart for the same price. Other product lines are not immune to the disturbing trend and we are seeing the first signs of reduced profitability and decreasing projected growth in the organics segment for SmartMart. Researchers and scientists who work at SmartMart have created a new standard in organic practices which seeks to push the envelope on sustainable practices. Organics 2.0 is a new concept which surpasses the old standard in several ways: 1. In addition to additives and artificial processing, Organics 2.0 takes into account a product's carbon footprint. Currently there...

Words: 568 - Pages: 3

Free Essay

Leg 500 Assignment

...Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Property Daniel A. Sievers Professor: Joe McGirt Strayer University LEG 500 12/01/2014 Research three to five issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. There are many issue’s relating to advertising, intellectual property and regulation in today's workplaces. All phases of marketing and advertising mix are subject to laws and limitations. Every marketing supervisor will be faced with how they must discuss ethics and law when marketing their products. Any marketing manager understands that there are cut and dry solutions to ethical issues that will occur during the normal course of business (Pharmaceuticals, n.d.). The Bureau of Consumer Protection’s places everything in perspective that all communication in the United States must be truthful. The Federal Trade Commission Act (FTC) looks for dishonesty and deception towards customers that try to change their decision to purchase medications. FTC monitors truth-in-advertising laws especially with kids, but there have been a lot of immoral practices in advertisements over time. The most moral decision is not to promote to children but in this case to the parent. Children's ad urges children to get dependent on products that induce on social development (Media, 2004). Cigarette advertising is matched to marketing consumers...

Words: 2683 - Pages: 11

Premium Essay

John Case

...| Dewey, Chetum, and Howe | Memo To: Dewey, Chetum, and Howe | | From: | XXXXX | cc: | Dewey, Chetum, and Howe | Date: | December 4, 2015 | Re: | PharmaCare (John) | | | As requested, I am writing this memo to provide details about a case that has been brought before us at Dewey, Chetum, and Howe. John, a past pharmacist at PharmaCARE, came into the firm with apprehensions of PharmaCARE’s usage of AD23, the establishment’s number one selling diabetes drug. A few years ago PharmaCARE’s study showed the AD23 would also slow the advancement of Alzheimer’s disease. This led John and the other pharmacologists that he led to reformulate the drug to capitalize on its outcome. To evade the Food and Drug Administration’s (FDA) inspection, PharmaCARE founded an exclusively held company, CompCARE, to function as a compounding pharmacy. This company would retail the new invention to people by prescription only. CompCARE profited from PharmaCARE’s standing, records, systems, and trades and marketing skill, and within several months the health community was talking about AD23. Response was good, mainly amongst Medicare, Medicaid, and Veterans Affairs patients. Realizing the chance to get additional income, CompCARE started marketing AD23 straight to customers and promoting AD23 right to clinics, hospitals, and physician offices, although compounding pharmacies are not allowed to market medicines in large qualities for common use. To dodge this provision, CompCARE pushed...

Words: 1890 - Pages: 8

Free Essay

Leg 500 Assignment 4 Week 10

... 4 RUNNING HEAD: LEGAL AND ETHICAL CONSIDERATIONS IN MARKETING, PRODUCT SAFETY AND INTELLECTUAL PROPERTY LEGAL AND ETHICAL CONSIDERATIONS IN MARKETING, PRODUCT SAFETY AND INTELLECTUAL PROPERTY [Student Name] [Instructor’s Name] [Date] [Course Name] Introduction This paper is concern with legal and ethical issues in advertising, marketing, regulations and intellectual property of product safety with respect to PharmaCARE which is a pharmaceutical company. The paper includes the information regarding drug companies, Direct to Consumers (DTC) marketing. Next we will determine the role of Food and Drug Administration (FDA) in regulatory schemes of pharmacies and determine that whether FDA empower over compounding pharmacies. In this paper, I have to make decision about PharmaCARE that whether the company use of intellectual property of Colberia. After this, I will analyze PharmaCARE ways to use US laws to protect intellectual property to coop with intellectual property in Colberia. To compensate the people of suffered from damages due to usage of AD23 will be studied and different suggestions will be made to compensate them. In the end, three changes will be recommended to PharmaCARE to go forward ethically. 1-Ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question...

Words: 2296 - Pages: 10

Premium Essay

Should the Fda Regulate Vitamins and Dietary Supplements?

...Abhitej Nibber YR7544 NEWS MEMO 2- Food Politics Should the FDA regulate Vitamins and Dietary supplements? How healthy are the Vitamins and Dietary supplements that promise to promote good health? Vitamins and other Dietary supplements have no set boundaries since the law that regulates this industry, The Dietary Supplements Health and Education Act of 1994 took the legal control and jurisdiction power away from the Food and Drug Administration (FDA). This law was passed in 1994 by the Congress and signed by the president and resulted in a piece of legislation called the Dietary Supplement Health and Education Act (DSHEA) of 1994.This legislation limits the FDA’s power to regulate dietary supplements. These Vitamins and Supplements have long been known to have potential serious health consequences and can also lead to death. Excess and improper consumption of these supplements can cause Liver damage, reduced bone strength, Cancer and cause birth defects. Excess of iron may lead to vomiting and nausea, harmful during pregnancy and nursing, harmful to children, increased risk of high blood pressure, heart attack, stroke and various other cardiovascular problems. The safety and health is endangered by the unregulated dietary supplements, but the dollars the industry is spending serves to dampen congressional concern over the issue,” said Ms. Sloan.  “Heartbreakingly, this kind of money spending is highly usual as it has a great impact.  Industries facing a threat...

Words: 782 - Pages: 4

Free Essay

Ethics

...FORTUNE -- It was a humiliating moment. Congressman Edolphus Towns was upbraiding a top Johnson & Johnson executive. Certainly Towns (D-N.Y.), the chairman of the House Committee on Oversight and Government Reform, has browbeaten his share of CEOs and Wall Street titans. But it's not the sort of thing that usually happens to J&J. At this hearing in May, though, Towns laid into the health care giant. "The information I've seen during the course of our investigation raises questions about the integrity of the company," he boomed. "It paints a picture of a company that is deceptive, dishonest, and has risked the health of many of our children." That's a damning indictment for any business, but an especially shocking one for Johnson & Johnson (JNJ, Fortune 500), one of America's most iconic and trusted brands -- the one whose products you give your children. For more than a century J&J has built a sterling reputation as the maker of such products as Band-Aids, Baby Shampoo, and Tylenol. It considers its business a mission -- at least according to its credo, which pledges responsibility first "to the doctors, nurses, and patients, to mothers and fathers and all others who use our products and services." But serious questions have been raised about the quality of numerous J&J products. Since September 2009, McNeil Consumer Healthcare, the J&J division that makes over-the-counter (OTC) drugs, has announced eight recalls, including one for an estimated 136 million...

Words: 3647 - Pages: 15

Premium Essay

Hearts 'R Us Preferred Stock Classification

...MEMO To: Borg Re: Preferred stock classification Facts Borg (the Company) is an early-stage research and development medical device company. Borg has no current products in the marketplace but is in the final stages of going to market with the Heart Valve System. All preliminary trials have been approved by the FDA, and the Company is in the final trial; once the final trial is complete, the Company will present the product to the FDA for final approval. If approved by the FDA, the Heart Valve System will revolutionize the way medical professionals repair heart valve defects. Bionic Body (“Bionic”), a SEC registrant, is a biological medical device company that focuses on the development of implantable biological devices, surgical adhesives, and biomaterials. Bionic could benefit from the approval of the Heart Valve System since it has a supplementary device that could be used in tandem with the Heart Valve System. As part of a financing strategy to support its operations, Borg sold Bionic $3.5 million of Series A Preferred Shares (the “Shares”) of the Company with a par value of $1 per Share. The transaction was completed on November 30, 2011. As part of the Series A Preferred Stock purchase agreement, Bionic has the following rights: * Board Rights — as the holder of the preferred stock, Bionic is entitled to appoint one member to the Company’s board of directors (the “Board”). In addition, Bionic has the right to appoint an observer to receive all information provided...

Words: 3624 - Pages: 15

Premium Essay

Project Management

...AMPM600 Project Management Assignment 2, Microsoft Project 2013 2015, Semester Two Due Date: 13 Nov 2015 Instructions: On the following page Student name/number ………………………………….……………………… SEMESTER 2, 2015 Individual Assignment AMPM600 Introduction to Project Management This individual assignment is a computer project derived from the POM+ Project exercises of the textbook Project Management the Managerial Process. DUE DATE: See course outline for due dates throughout the semester. INSTRUCTIONS:         This assignment must be completed individually, using MS Project 2010 or 2013 and MS Word. Answer ALL questions. All written work must be typed in 12 font, 1.5 line spacing and meet business standards. All PDF Reports must include your student ID in the footer. You may request feedback from your lecturer to verify the accuracy of your project files. However, you must be specific in your requests and any request must be in relation to the usage of Microsoft Project. You must upload your project files to Moodle, see your course outline for due dates. That is 1 MS Project file and 1 Word file for each part and PDF’s as required. All assignment work must be your own. You must save your project file after each part with the file name containing your Student ID, Last Name, First Name, Project Name, Assignment Part. E.G. 1234567_Rob Meadows_POM+Project_Part1.mmp  Refer to the Course Outline for the assignment submission schedules...

Words: 2401 - Pages: 10

Premium Essay

Legal and Ethical Considerations in Marketing

...top-selling drug AD23. John and his team of pharmacists discovered that the drug could slow down the progression of Alzheimer’s. Therefore, his team reformulating the drug to maximize the effect of the drug without the approval from Federal and Drug Administration. In this paper, I will evaluate three ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety, as well as, analyze whether PharmaCare violated any of the issues in questions. I will argue the pros and cons of Direct-to-Consumer (DTC) Marketing by drug companies. I will determine which parties were responsible for regulating compounding pharmacies under the current regulatory scheme. Also, the actions that either party, or the FDA could/ should have taken in this scenario; whether PharmaCare could face legal exposure surrounding its practices. I will analyze whether or not the PharmaCare used U.S. Law to protect its own intellectual property, and if John (the client) has any claim of being the true “inventor” of AD23. I will present at least three ways the company could compensate John for the use of his intellectual property if he had followed proper protocol. I will summarize one example of intellectual theft, as well as, examine the effect on that company’s brand. Next, I will analyze the potential issues surrounding the death of John’s wife and other potential litigants against PharmaCare resulted to AD23. Last, I will specify and justify the major...

Words: 3335 - Pages: 14

Premium Essay

Tengion Case Study

...Case memo question: Should Tengion prioritize Augment or Conduit as its lead product? Tengion is a relatively new biotech company which focuses its efforts in building regenerative medicine. This is a niche field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late 2008 Tengion management faces a difficult dilemma. In light of the financial crises, the company needs to manage cash burn by prioritizing its R&D efforts. CEO Nichtberger needs to recommend to the board which of two promising new medical treatments to keep developing while placing the other on hold. In comparing the two options, a host of factors need to be considered-- these range from assessing the regulatory challenges, manufacturing challenges, marketing challenges (in particular pricing), and partnering challenges. Each of the treatments would target a unique patient population that differs in both size and composition. Tengion must also consider how quickly it might expect to bring each of the two treatments to market. The decision could have significant long-term implications for the company's ultimate survival and success. Tengion’s lead product Augment was primarily targeted towards patients suffering from Spina bifida (SB) and spinal cord injury (SCI) whose bladders did not function properly. There were 2,000 new cases (babies) of Spina bifida (SB) every year and 12,000 new cases of spinal...

Words: 1079 - Pages: 5

Premium Essay

The Ethics Game Simulation

...assurance within their industry. The first scenario took place after the Lab Director informed the Quality Control Manager that specimens received at his lab were found with a trace contamination of 100% in all the samples. Unfortunately these results were two weeks late and products from these specimens had already been released and shipped out to consumers. Although the contamination found was well below FDA standards, the QCM is faced with many concerning issues and decisions to be made. A few examples are; who needed to be informed and how quickly, how would information should be disseminated without creating a threat or scare to the public and stakeholders. How serious was this contamination and how much product was actually sent out. This also includes to what degree of ethics and legal concerns would need to address. Nevertheless, there are many concerning factors. As a manager, gathering all the facts is an important first step. Who to inform and how this information will be shared by either memo or email. Immediately the QCM contacted the Quality Operations Director by memo. The QCM recommendations included contacting the Legal and Marketing department for consultant prior to any proceedings of informing stakeholders or consumers. The integrity and values were largely at stake, not to mention the company’s reputation and strong commitment to...

Words: 731 - Pages: 3

Free Essay

Scandals

...BEECH-NUT’S APPLE JUICE By Donna J. Wood and Alden Detwiler During the 1970s and early 1980s, the Beech-Nut Nutrition Corporation, with primary plant facilities at Canajoharie, New York, and headquarters near Philadelphia, was the second largest maker of baby foods in the United States, with roughly a 15 percent market share (comparable to Heinz’s market share), compared to Gerber’s 70 percent. From its origins as a meatpacker in 1891 to its modern status as a diversified food manufacturer, the company had built a reputation for pure, natural, high-quality products (Welles, 1988; Traub, 1988). In 1973, lawyer Frank Nicholas and a group of colleagues bought the baby foods division of Beech-Nut from Squibb Corporation, which had acquired the company in 1969. The new owners were undercapitalized and overloaded with debt from the beginning, and the company began to lose money. Beech-Nut signed an agreement in 1977 with a wholesaler run by Zeev Kaplansky, Interjuice Trading Corporation, to purchase apple juice concentrate. Interjuice was able to offer concentrate well below the market price (Welles, 1988), an opportunity that Beech-Nut was reluctant to turn down, given its financial troubles. By 1978, with apple juice products accounting for 30 percent of total sales, the Interjuice contract provided significant cost savings to a firm deeply in debt (Welles, 1988). Early savings from the contract amounted to about $250,000 a year on a $50 million operating budget....

Words: 3659 - Pages: 15

Premium Essay

Preferred Stocks

...a young private research and development medical device company, sold $3.5 million of its Series A Preferred Shares on November 30, 2011 to Bionic Body (“Bionic”). This transaction gave the company enough financing for their heart valve system which they hope will revolutionize the way heart valve defects are repaired. In order to make this product available for sale they need a final approval by the FDA. The shares sold to Bionic have a par value of $1 per share and the purchase has given Bionic the following five rights: Board rights Mandatory Conversion Right Contingent Redemption Right Additional Protective Rights Right of First Refusal and Co-Sale Rights After Year 4, Hearts is still in the process of filing for FDA approval. The clinical testing and administrative process for filing for the FDA approval have taken much longer than initially anticipated. In addition, the trial results have been worrisome because of certain post-surgery issues that have been experienced by patients who received the Heart Valve System. It is certain the product will not receive FDA approval by end of Year 5. Hearts had planned to have an initial public offering (IPO) in the future. --- Whether the preferred stocks should be classified (treated) as a (debt/equity) is an accounting issue because of the guidance of the ASC Codification 815-15-25 (Derivatives and Hedging, Embedded Derivatives, Recognition) paragraph 17 shown below; 25-17 Because the changes in fair value of...

Words: 1989 - Pages: 8

Premium Essay

Memorandum

...To: Carol Cleaver, Instructor From: Adam Henn Date: Oct. 9, 2012 ------------------------------------------------- Re: Case Study No. 1 ------------------------------------------------- I appreciate this opportunity to assist you in this assignment and address the board with my findings. As per the assignment I have researched the following topic from the course materials. “Illness and death associated with the consumption of energy drinks”, and I have reached the following conclusions: 1. There are potential risks associated with energy drinks in children and adolescents 2. Sale of energy drinks has been debated and or restricted in various places 3. Many ingredients are understated and not regulated Within this memo I will explain my conclusions. I will be presenting my analysis in three parts. The first section addresses potential risks in children and adolescents. The next section about the debates and regulation of energy drink sales. The final section regards the ingredients that are understated or not regulated in some countries and states. Potential Risks to Children and Adolescents For my analysis I began by reviewing “Energy drinks 'potentially dangerous for children' say doctors. Energy drinks could be dangerous for children and teenagers, doctors have warned.” Found on www.telegraph.co.uk. As a responsible company we should be liable to research and warn consumers of the possible risks associated with the consumption of our products...

Words: 972 - Pages: 4

Free Essay

Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Property

...March 3, 2016 Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Property Legal 500 Professor Carter Introduction In the book Pharmaceutical Ethics, Jon Merrills’ defines ethics as: * Ethics is the systematic study of what is right and good with respect to conduct and character. * The beliefs and behaviors to which members of the profession subscribe. * A critical evaluation of assumptions and arguments. * A discussion about what ought to be done or ought not to be done. Using Merrill’s’ definitions as a rough guide we can evaluate the legal and ethical decisions of PharmaCARE’s use of the diabetic drug AD23 in slowing the progression of Alzheimer’s disease. The drug was reformulated to maximize its effect on Alzheimer’s treatment however, PharmaCARE took actions to avoid the Food and Drug Administration in the reformulated drug for Alzheimer. PharmaCARE setup its own pharmacy company CompCARE to sell the new formulation to the public. CompCARE was able to take advantage of PharmaCARE’s databases, networks, and sales and marketing expertise to create a high demand of the product. Once the high demand was there, CompCARE started to advertise AD23 directly to consumers and marketing the drug directly to hospitals, clinics and physicians. After the success of AD23 CompCARE was sold to WellCO. Two weeks later AD23 was linked to 200 cardiac deaths. Research three to five (3-5) ethical issues relating to marketing...

Words: 2197 - Pages: 9